Study: Atrazine poses no cancer risk in drinking water
A new report in the March 2013 issue of European Journal of Cancer Prevention states atrazine appears to be a good candidate for a category of herbicides with a probable absence of cancer risk. The authors, Boffetta et. al, recommend that atrazine continue to be treated for regulatory and public health purposes as an agent unlikely to pose a cancer risk to humans. They reviewed reports from the U.S. Environmental Protection Agency (EPA) and the July 2011 EPA Scientific Advisory Panel to determine whether epidemiologic studies suggested a link between atrazine and specific cancers. A weight-of-evidence analysis concluded “that there is no causal association between atrazine and cancer.”
These findings are consistent with the Agricultural Health Study, a large multiyear study sponsored by the National Cancer Institute, the National Institute of Environmental Health Sciences as well as EPA. Other government agencies and independent organizations — including the World Health Organization and regulatory agencies in the United Kingdom, Canada, and Australia — have reached similar conclusions.
- Irrigation Association to release online courses with Cal Poly
- Monsanto to invest $120 million in Argentina
- Ag markets ended Tuesday mostly lower
- Fat molecules influence function of key photosynthesis protein
- Monsanto honored for efforts in developing agriculture in Vietnam
- Corn stocks top 1.2 billion bushels
- U.S. GMO labeling foes triple spending in first half of this year
- Source shows half of GMO research is independent
- Activists fighting Golden Rice even more in 2014
- White House issues veto threat on bill to block WOTUS rule
- How much corn can the ethanol industry use?
- East-West Seed signs marketing collaboration with Monsanto